Yuxiang Liang
Zhejiang A & F University(CN)Guangxi University(CN)Shanxi Medical University(CN)Sichuan University(CN)China Aerodynamics Research and Development Center(CN)Chinese PLA General Hospital(CN)West China Hospital of Sichuan University(CN)Sichuan Cancer Hospital(CN)Zhejiang Lab(CN)Hainan General Hospital(CN)Sichuan Provincial Hospital of Traditional Chinese Medicine(CN)State Key Laboratory of Respiratory Disease(CN)Guilin University of Electronic Technology(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, RNA Research and Splicing, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, RNA modifications and cancer
Most-Cited Works
- → miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer(2015)152 cited
- → Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer(2016)120 cited
- → MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1(2013)110 cited
- → RETRACTED ARTICLE: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer(2017)106 cited
- → CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer(2008)104 cited
- → The high concentration of progesterone is harmful for endometrial receptivity and decidualization(2018)95 cited